STEPHEN HAHN to Skin Diseases
This is a "connection" page, showing publications STEPHEN HAHN has written about Skin Diseases.
Connection Strength
0.042
-
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. Clin Cancer Res. 2002 May; 8(5):1065-72.
Score: 0.042